Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Autori principali: Macarena Orejudo (Autore), Raul R. Rodrigues-Diez (Autore), Raquel Rodrigues-Diez (Autore), Ana Garcia-Redondo (Autore), Laura Santos-Sánchez (Autore), Javier Rández-Garbayo (Autore), Pablo Cannata-Ortiz (Autore), Adrian M. Ramos (Autore), Alberto Ortiz (Autore), Rafael Selgas (Autore), Sergio Mezzano (Autore), Carolina Lavoz (Autore), Marta Ruiz-Ortega (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...